8 research outputs found
Error Performance of Rectangular Pulse-shaped OTFS with Practical Receivers
application/pdfIEEE Wireless Communications Letters. 2022, 11 (12), P.2690-2694journal articl
鉄鋼材料破壊靱性のメゾメカニックス的解析
名古屋大学Nagoya University博士(工学)名古屋大学博士学位論文 学位の種類:博士(工学) (課程) 学位授与年月日:平成17年3月25日doctoral thesi
たばこ煙の充填層濾過ならびに性状と成分組成の評価に関する研究
学位記号番号 : 博理工甲第1106号博士の専攻分野の名称 : 博士(工学)
学位授与年月日 : 平成30年9月21日textapplication/pdfthesi
English Instruction and the Formation of Future Self Image : Activities Integrating Second Language and Visual Art Learning Practices
departmental bulletin pape
HER2 Targeted Breast Cancer Therapy with Switchable “Off/On” Multifunctional “Smart” Magnetic Polymer Core–Shell Nanocomposites
Multifunctional magnetic polymer
nanocombinations are gaining importance in cancer nanotheranostics
due to their safety and their potential in delivering targeted functions.
Herein, we report a novel multifunctional core–shell magnetic
polymer therapeutic nanocomposites (NCs) exhibiting pH dependent “Off–On”
release of drug against breast cancer cells. The NCs are intact in
blood circulation (“Off” state), i.e., at physiological
pH, whereas activated (“On” state) at intracellular
acidic pH environment of the targeted breast cancer cells. The NCs
are prepared by coating the cannonball (iron nanocore) with hydrophobic
nanopockets of pH-responsive poly(d,l-lactic-<i>co</i>-glycolic acid) (PLGA) polymer nanoshell that allows efficient
loading of therapeutics. Further, the nanocore–polymer shell
is stabilized by poly(vinylpyrrolidone) (PVP) and functionalized with
a targeting HER2 ligand. The prepared Her–Fe<sub>3</sub>O<sub>4</sub>@PLGA–PVP nanocomposites facilitate packing of anticancer
drug (Tamoxifen) without premature release in the bloodstream, recognizing
the target cells through binding of Herceptin antibody to HER2, a
cell surface receptor expressed by breast cancer cells to promote
HER2 receptor mediated endocytosis and finally releasing the drug
at the intracellular site of tumor cells (“On” state)
to induce apoptosis. The therapeutic efficiency of hemo/cytocompatible
NCs drug delivery system (DDS) in terms of targeted delivery and sustained
release of therapeutic agent against breast cancer cells was substantiated
by <i>in vitro</i> and <i>in vivo</i> studies.
The multifunctional properties of Her–Tam–Fe<sub>3</sub>O<sub>4</sub>@PLGA–PVP NCs may open up new avenues in cancer
therapy through overcoming the limitations of conventional cancer
therapy
